Severe/extreme obesity: A medical disease requiring a surgical treatment?

Acta Clinica Belgica

Volumn 54, Issue 3, 1999, Pages 154-161

  Scheen, A J ^a,b   Luyckx, F H ^a   Desaive, C ^a   Lefebvre P J ^a  

^a CHU SART TILMAN   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Bariatric surgery; Complications; Gastroplasty; Obesity; Weight loss

Indexed keywords

ARTICLE; GASTROPLASTY; HUMAN; MORBID OBESITY; OBESITY; STOMACH BYPASS; SURGICAL TECHNIQUE; TREATMENT INDICATION;

EID: 0032807676     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1080/17843286.1999.11754222     Document Type: Article

References (44)

1. Rosenbaum M, Leibel RL, Hirsch J. Obesity. N Engl J Med. 1997; 337: 396-405.
2. James WPT. A public health approach to the problem of obesity. Int J Obesity: 1995; 19 (suppl 3): S37-S45.
3. Stam-Moraga MC, Kolanowski J, Dramaix M, et al. Trends in the prevalence of obesity among Belgian men at work, 1977-1992. Int J Obesity. 1998; 22: 988-92.
4. Expert Panel. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med. 1998; 158: 1855-67.
5. National Institutes of Health Consensus Development Conference Statement. Gastrointestinal surgery for severe obesity. Am J Clin Nutr. 1992; 55: 615S-9S.
6. Bray GA, Ryan DH. Drugs used in the treatment of obesity. Diabetes Rev. 1997; 5: 83-103
7. Knol JA. Management of the problem patient after bariatric surgery. Gastroenterol Clin N Am. 1994; 23: 345-69.
8. Desaive C. Surgery for morbid obesity. Acta Chir Belg. 1996; 96: 192-6.
9. Kolanowski J. Surgical treatment for morbid obesity. Br Med Bull. 1997; 53: 433-45.
10. Krai JG. Surgical treatment of obesity. In: GA Bray, C Bouchard, WPT James (eds). Handbook of obesity. New York-Basel-Hong Kong, M Dekker, 1998: 977-93.
11. Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion. World J Surg. 1998; 22: 936-46.
12. Jung RT. Obesity as a disease. Br Med Bull. 1997; 53: 307-21.
13. Kolanowski J. (Ed). Recent progress in overweight and obesity. Acta Clin Belg. 1992; 47 (Suppl 14): 1-54.
14. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983; 67: 968-77.
15. Scheen AJ, Paquot N, Letiexhe MR, Paolisso G, Castillo MJ, Lefèbvre PJ. Glucose metabolism in obese subjects: lessons from OGTT, IVGTT and clamp studies. Int J Obesity. 1995; 19 (Suppl 3): S14-S20.
16. Van Gaal L, Zhang A, Steijaert MM, De Leeuw IH. Human obesity: from lipid abnormalities to lipid oxidation. Int J Obesity. 1995; 19 (Suppl 3), S21-S26.
17. Vansant G, Mertens A, Muls E. Determinants of postprandial lipemia in obese women. Int J Obesity. 1999; 23 (Suppl 1): 14-21.
18. Kolanowski J. Obesity and hypertension from pathophysiology to treatment. Int J Obesity. 1999; 23 (Suppl 1): 42-46.
19. Scheen AJ, Luyckx FH. Medical aspects of obesity. Acta Chir Belg. 1999; in press.
20. Scheen AJ. Insulin resistance syndrome and atherosclerotic cardiovascular disease. Acta Clin Belg. 1996; 51: 65-9.
21. Pi-Sunyer FX. A review of long-term studies evaluating the efficacy of weight loss in ameliorating disorders associated with obesity. Clin Ther. 1996; 18: 1006-35.
22. Garrow JS. Treatment of obesity. Lancet. 1992; 340: 409-13.
23. Scheen AJ, Desaive C, Lefèbvre PJ. Therapy for obesity - today and tomorrow. Baillière's Clin Endocrinol Metab. 1994; 8: 705-27.
24. Bray GA. Pharmacological treatment of obesity. In: GA Bray, C Bouchard, WPT James (eds). Handbook of obesity. New York-Basel-Hong Kong, M Dekker, 1998: 953-75.
25. Scheen AJ, Lefèbvre PJ. Pharmacological treatment of obesity: present status. Int J Obesity. 1999; 23 (Suppl 1): 47-53.
26. Kolanowski J. A risk-benefit assessment of anti-obesity drugs. Drugs Safety. 1999; 20: 119-31.
27. Desaive C. A critical review of a personal series of 1000 gastroplasties. Int J Obesity. 1995; 19 (Suppl 3): S56-60.
28. Luyckx FH, Scheen AJ, Desaive C, Dewé W, Gielen JE, Lefèbvre PJ. Effects of gastroplasty on body weight and related biological abnormalities in morbid obesity. Diab Metab. 1998; 24: 355-61.
29. Belachew M, Jacquet P, Lardinois F, Karler C. Vertical banded gastroplasty vs adjustable silicone gastric banding in the treatment of morbid obesity: a preliminary report. Obes Surg. 1993; 3: 275-8.
30. Renquist KE, Cullen JJ, Barnes D, Tang S, Doherty C, Mason EE. The effect of follow-up on reporting success for obesity surgery. Obes Surg. 1995; 5: 285-92.
31. Luyckx FH, Desaive C, Thiry A et al. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. Int J Obesity. 1998; 22: 222-6.
32. Scheen AJ. Lessons from the discovery of leptin: is obesity an endocrine disease? Acta Clin Belg. 1996; 51: 371-6.
33. Luyckx F, Letiexhe M, Scheen AJ, Gielen J, Lefèbvre PJ. Le dosage de la leptine sérique: un intérêt en biologie clinique? (Abstract) Acta Clin Belg. 1998; 53: 124-125.
34. Letiexhe MR, Scheen AJ, Gérard PL, Desaive C, Lefèbvre PJ. Post-gastroplasty recovery of ideal body weight normalizes glucose and insulin metabolism in obese women. J Clin Endocrinol Metab. 1995; 80: 393-9.
35. Scheen AJ. Aggressive weight reduction treatment in the management of type 2 diabetes. Diab Metab. 1998; 23: 116-23.
36. Scheen AJ, Luyckx FH, Lefèbvre PJ. The place of bariatric surgery in the management of the obese Type 2 diabetic patient. Int Diabetes Monitor. 1998; 10 (No 6): 1-7.
37. Scheen AJ, Lefèbvre PJ. The management of the obese diabetic patient. Diabetes Rev. 1999; 7: in press.
38. MacDonald KG, Long SD, Swanson MS et al. The gastric bypass operation reduces the progression and mortality on non-insulin-dependent diabetes mellitus. J Gastrointest Surg. 1997; 1: 213-20.
39. Sjöström L, Larsson B, Backman L et al. Swedish obese subjects (SOS). Recruitment for an intervention study and a selected description of the obese state. Int J Obesity. 1992; 16: 465-79.
40. Michielsen D, Van Hee R, Hendrickx L. Complications of biliopancreatic diversion surgery as proposed by Scopinaro in the treatment of morbid obesity. Obesity Surg. 1996; 6: 416-20.
41. Belachew M, Legrand M, Vincent V, Lismonde M, Le Docte N, Deschamps V. Laparoscopic adjustable gastric banding. World J Surg. 1998; 22: 955-63.
42. Scheen AJ. Mise au point médicale avant gastroplastie: indications et contre-indications. Rev Méd Brux. 1996; 17: 232-5.
43. Benotti P, Forse R. The role of gastric surgery in the multidisciplinary management of severe obesity. Am J Surg. 1995; 169: 361-6.
44. Martin LF, White S, Lindstrom W Jr. Cost-benefit analysis for the treatment of severe obesity. World J Surg. 1998; 22: 1008-17.